Share Twitter LinkedIn Facebook Email Dr. Toshihiko Doi, MD of National Cancer Center Hospital East, Japan discusses clinical trial efforts in UGI cancers with the anti-PD-1 and PD-L1 monoclonal antibodies at ASCO GI 2016
FDA grants accelerated approval to ponatinib (ICLUSIG®) with chemotherapy for newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia Acute Lymphoblastic Leukemia 3 Mins Read
FDA Approves Inotuzumab Ozogamicin (BESPONSA) for Acute Lymphoblastic Leukemia in Pediatric Patients [Exclusive Video] Acute Lymphoblastic Leukemia 3 Mins Read
Spotlight on CAR T-cell Therapy in 2024: Advances & Clinical Insights Acute Lymphoblastic Leukemia 3 Mins Read